Cancer Therapy
A section of Cancers (ISSN 2072-6694).
Section Information
In the last decades, cancer therapies have substantially improved cancer care and patients’ survival. The introduction of targeted therapies had a major impact on the management of cancer. However, millions of people still die from cancer every year and cancer drug resistance remains the Achilles' heel of cancer chemotherapeutics. Thanks to our increasing knowledge and understanding of the pathology, new cancer cells phenotypes and drug targets have emerged in the last years. The role of the tumor microenvironment in cancer promotion and progression as well as the plastic and dynamic nature of the disease have been unraveled and now pave the way to the development of new and innovative therapeutic strategies. In this section of Cancers, we aim at rapidly publishing contributions on all aspects of Cancer Therapy. We encourage the submission of manuscripts providing new and innovative therapeutic approaches as well as papers describing technologies and models developed for the discovery and the delivery of anticancer drugs. Systematic and perspective reviews are also welcome. Topics include, but are not limited to:
- Cancer therapeutics
- Targeted therapy
- Drug discovery
- Drug repurposing
- Structure-based design
- Target-based design
- Tumor drug delivery
- Tumor drug distribution
- Drug resistance
- Precision medicine
- Gain/loss of function screening
- Cancer cell plasticity
- Cancer cell metabolism
- Cell cycle checkpoint
- DNA repair
- Tumor-microenvironment interactions
- Extracellular vesicles
- Tumor heterogeneity
- Combination therapies
- Adaptive therapy
- Rechallenge therapy
- Radiotherapy
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Advances in Treatment for Hepatobiliary and Pancreatic Cancers: Multi-Disciplinary Strategies and Outcome Evaluation (Deadline: 30 September 2023)
- Hereditary Syndromes and Radiation (Deadline: 30 September 2023)
- EGFR-Mutated Non-small Cell Lung Cancer (Deadline: 30 September 2023)
- DNA Damage and Repair in Cancer Risk Prediction (Deadline: 30 September 2023)
- Management of Glioblastomas (Deadline: 30 September 2023)
- Clinical Development of Drugs and Drug Combinations Modulating Immune Checkpoints in Cancer Therapy (Deadline: 30 September 2023)
- Advances in Liver Cancer: Radiotherapy, Systemic Therapy and Upcoming Trends (Deadline: 30 September 2023)
- New Insight of Non-small Cell Lung Cancer (Deadline: 30 September 2023)
- Advances of Brain Mapping in Cancer Research (Deadline: 30 September 2023)
- Treatment Intensification in Localized Prostate Cancer: What Route with What Car? (Deadline: 30 September 2023)
- Integrated Management of Cancer (Deadline: 30 September 2023)
- Local Ablation Therapy in Liver Cancer (Deadline: 30 September 2023)
- CAR T Cell Therapy for Cancers (Deadline: 30 September 2023)
- New Insights in Thoracic Sarcoma (Deadline: 30 September 2023)
- Venous Thromboembolism and Cancer (Deadline: 30 September 2023)
- Targeted Therapies for Pediatric Solid Tumors (Volume II) (Deadline: 30 September 2023)
- Systemic Therapy for Hepatocellular Carcinoma (Deadline: 30 September 2023)
- Current Trends for Sinonasal Carcinoma (Deadline: 30 September 2023)
- Cardio-Oncology: An Emerging Paradigm in Modern Medicine (Deadline: 30 September 2023)
- Advanced Pancreatic Cancer (Deadline: 30 September 2023)
- Chemotherapy for Hematologic Malignancies (Deadline: 30 September 2023)
- Recent Developments of Histone Deacetylase Inhibitors as Anticancer Agents (Deadline: 30 September 2023)
- Penile Carcinoma (Deadline: 10 October 2023)
- Personalized Radiotherapy in Cancer Care (Deadline: 10 October 2023)
- New Insights into Prostate Cancer Radiotherapy (Deadline: 15 October 2023)
- Neoadjuvant Therapies in Pancreatic Cancer (Deadline: 15 October 2023)
- Thoracic Neuroendocrine Tumors and the Role of Emerging Therapies (Deadline: 15 October 2023)
- Locally Advanced and Recurrent Rectal Cancer (2nd Edition) (Deadline: 15 October 2023)
- IECC2023: New Targets for Cancer Therapies (Deadline: 15 October 2023)
- Past, Present, and Future Strategies in the Treatment and Management of Gliomas (Deadline: 15 October 2023)
- The Evolving Role of Immunotherapy and Radiotherapy in the Non-operative Management of Esophageal and Rectal Cancer (Deadline: 15 October 2023)
- Radiation Therapy for Brain Tumors (Deadline: 15 October 2023)
- Advances in Chordoma (Deadline: 15 October 2023)
- Novel Combinatorial Approaches for Immunotherapy and Targeted Therapies in Cancer (Deadline: 15 October 2023)
- Radiation Therapy in Lymphoma (Deadline: 20 October 2023)
- Radiation Therapy in Primary Liver Cancers (Deadline: 20 October 2023)
- Salvage Therapy for Recurrent Prostate Cancer—Optimizing Oncological and Functional Outcomes (Deadline: 20 October 2023)
- Updates on Chronic Lymphocytic Leukemia (Deadline: 20 October 2023)
- Advances and Future Developments in Liver Transplantation for Cancers (Deadline: 27 October 2023)
- Adjuvant Chemotherapy for Pancreatic Cancer (Deadline: 30 October 2023)
- RAS Signaling Pathway in Cancer Therapy (Deadline: 30 October 2023)
- Targeting mTOR in Cancer Therapy (Deadline: 30 October 2023)
- Advances in Penile Cancer Research from the Bench Side to the Patients (Deadline: 31 October 2023)
- Third Edition of Gynecological Cancer (Deadline: 31 October 2023)
- Targeting Incurable Cancers (Deadline: 31 October 2023)
- Recent Advances in Ovarian Cancer Surgery (Deadline: 31 October 2023)
- Targeted Therapy in Gastrointestinal Cancer (Deadline: 31 October 2023)
- Current Use of PSMA in Prostate Cancer Treatment (Deadline: 31 October 2023)
- Low Grade Gliomas (Deadline: 31 October 2023)
- Concepts to Improve Targeted Radionuclide Therapy in Cancer: Ligand Design Optimization and Application of Emerging Radionuclides and Combination Therapies (Deadline: 31 October 2023)
- Cancer and Non-cancer Effects following Ionizing Irradiation (Deadline: 31 October 2023)
- Current Role of Ablation in Liver Cancer Therapy (Deadline: 31 October 2023)
- PARP Inhibitors: Targeting DNA Damage Repair in Cancer Treatment (Deadline: 31 October 2023)
- Advances in Diagnostics and Treatment of Head and Neck Cancer (Deadline: 31 October 2023)
- Advances in Surgical Treatment of Pancreaticobiliary Cancers (Deadline: 31 October 2023)
- Non-Melanoma Skin Cancer: Advances Towards Prevention and Personalized Medicine in Clinical Practice (Deadline: 31 October 2023)
- Radiotherapy for Thoracic Malignancies: New Advances and Challenges (Deadline: 31 October 2023)
- Oncology: State-of-the-Art Research and Initiatives in Japan (Deadline: 31 October 2023)
- Unravelling Cancer Mechanism and Developing Novel Therapeutics: An Urgent Need to Treat Cancer (Deadline: 31 October 2023)
- Hypofractionated Radiotherapy in Cancer Treatments (Deadline: 31 October 2023)
- Novel Targeted Therapies in Brain Tumors (Deadline: 31 October 2023)
- Novel Therapeutic Targets for the Treatment of Multiple Myeloma (Deadline: 31 October 2023)
- Overcoming Drug Resistance to Systemic Therapy in Breast Cancer (Deadline: 1 November 2023)
- New Insights on Therapy in Hepatocellular Carcinoma (Deadline: 1 November 2023)
- Recent Advances in Myelodysplastic Syndromes: Diagnosis, Prognosis and Clinical Therapy (Deadline: 1 November 2023)
- Surgical Management of Gastrointestinal Cancers (Deadline: 1 November 2023)
- Advances in Ovarian Cancer Research and Treatment (Deadline: 4 November 2023)
- Topic on Immunotherapy and Tumor Microenvironment in Lymphoma (Deadline: 9 November 2023)
- Advances in Melanoma Treatments: Molecular Targeted Therapies, Immunotherapies and Vaccines (Deadline: 10 November 2023)
- New Challenges in Gynaecological Cancers Diagnosis and Treatment (Deadline: 10 November 2023)
- Advances in Parathyroid Carcinoma: From Bench to Bedside (Deadline: 10 November 2023)
- Novel Insights in Myeloma (Deadline: 10 November 2023)
- State-of-the-Art in Eye Cancer (Deadline: 15 November 2023)
- Advances in the Surgical Treatment of Urologic Cancer (Deadline: 15 November 2023)
- Emerging Therapies in Management of Gastrointestinal Malignancies (Deadline: 15 November 2023)
- Advances in Thoracic Carcinoma and Translational Research (Deadline: 15 November 2023)
- Advances in Particle Therapy for Cancer Treatment and Research (Deadline: 15 November 2023)
- 2nd Edition: Advances in the Management of Thyroid Cancer (Deadline: 15 November 2023)
- Discovery, Development and Application of Innovative Approaches to Cancer Therapy (Deadline: 15 November 2023)
- Chromatin as a Target for Cancer Therapy (Deadline: 15 November 2023)
- Perspectives on Early-Stage Medullary Thyroid Cancer Treatment (Deadline: 15 November 2023)
- Endocrine Therapy for Breast Cancer (Deadline: 20 November 2023)
- Feature Review Papers on Advanced Gastric Cancer (Deadline: 20 November 2023)
- 2nd Edition of New Therapeutic Strategies for Acute Myeloid Leukemia (Deadline: 20 November 2023)
- Innovation in Surgical Treatment of Hepato Pancreatico Biliary (HPB) Cancers (Deadline: 26 November 2023)
- Treatment of Cancer-Associated Thrombosis 2.0 (Deadline: 30 November 2023)
- Novel Strategy and Technologies in Local and Locoregional Treatment for Lung Cancer (Deadline: 30 November 2023)
- New Concepts of Personalized Therapy in Salivary Gland Carcinomas (Deadline: 30 November 2023)
- Challenges of Radiotherapy for Head and Neck Cancer (Deadline: 30 November 2023)
- Personalized Treatment Strategies for Thyroid Carcinoma (Deadline: 30 November 2023)
- The Challenge of the Treatment: Radiotherapy of Brain Metastases (Deadline: 30 November 2023)
- From Bench to Bedside in the Management of Cholangiocarcinoma (Deadline: 30 November 2023)
- Recent Advances in Hepatobiliary Cancers: From Diagnosis to Treatment (Deadline: 30 November 2023)
- Cellular Plasticity: Tumorigenesis and Therapy (Deadline: 30 November 2023)
- Current Strategies in Pancreatic Cancer Management: Intense Systemic Treatment and Aggressive Local Tumor Control. When Shall We Do What? (Deadline: 30 November 2023)
- Carbon-Ion Radiotherapy of Cancers in Japan (Deadline: 30 November 2023)
- Brachytherapy for Gynecologic Malignancies (Deadline: 30 November 2023)
- Advances in Diagnosis, Treatment and Management of Endocrine Neoplasms (Deadline: 30 November 2023)
- Contemporary Surgical Management of Melanoma (Deadline: 30 November 2023)
- Management of Gastric Cancer (Deadline: 30 November 2023)
- New Insights into Oligo-Recurrence of Various Cancers (Deadline: 30 November 2023)
- Sonodynamic Cancer Therapy (Deadline: 30 November 2023)
- Robotic-Assisted Surgery in Cancers: New Technologies and New Strategies (Deadline: 30 November 2023)
- Surgical Management of Gastric Cancer: New Insights and Future Prospectives (Deadline: 30 November 2023)
- The Use of Targeted Cytokine for Novel Cancer Therapeutics (Deadline: 30 November 2023)
- Oral Squamous Cell Carcinoma–from Diagnosis to Treatment (Deadline: 30 November 2023)
- Current Status and Perspective of Immunotherapy for Head and Neck Squamous Cell Carcinoma (Deadline: 30 November 2023)
- Thymic Tumors: New Developments and Future Directions in Molecularly Informed Therapies (Deadline: 1 December 2023)
- Breast Cancers Treatments: Overcoming Drug Resistance (Deadline: 1 December 2023)
- Pituitary Tumors: Molecular Insights, Diagnosis, and Targeted Therapy (2nd Edition) (Deadline: 1 December 2023)
- Treatment of Lung Cancer (Deadline: 10 December 2023)
- Hodgkin Lymphoma: Recent Advances and Challenges (Deadline: 10 December 2023)
- Connexins in Cancer (Deadline: 10 December 2023)
- Advances in Hereditary Colorectal Cancer: Diagnosis and Treatment (Deadline: 10 December 2023)
- Recent Updates on Salivary Gland Tumors (Deadline: 12 December 2023)
- Updates on Urologic Oncology: From Diagnosis to Localized and Systemic Therapy Options (Deadline: 15 December 2023)
- Molecular Imaging in Tumor Evolution and Therapy Response (Deadline: 15 December 2023)
- Oropharyngeal Squamous Cell Carcinoma, Challenges and Opportunities (Deadline: 15 December 2023)
- Advances in TNBC: New Markers for Innovative Treatments (Deadline: 15 December 2023)
- How to Improve Chondrosarcoma Treatment? From Fundamental Research to Biomarker Discovery and Clinical Applications (Deadline: 15 December 2023)
- Cancer Chemotherapy Resistance (Deadline: 15 December 2023)
- Radiation Therapy for Modern Management of Bone Metastases (Deadline: 15 December 2023)
- Radiotherapy for Gastrointestinal Cancer (Deadline: 15 December 2023)
- ALK in Cancer: Lessons from the Future (Deadline: 15 December 2023)
- Vaginal Cancer: From Pathology to Treatment (Deadline: 15 December 2023)
- Carbon Ion Radiotherapy (Deadline: 15 December 2023)
- What Is New in the Treatment of Intraocular (Uveal) Melanoma (Deadline: 20 December 2023)
- Efficacy and Complications of Liver Resection for Liver Cancer (Deadline: 20 December 2023)
- Metastatic Colorectal Cancer 2.0 (Deadline: 20 December 2023)
- Hyperthermia-Based Cancer Treatments (Deadline: 20 December 2023)
- Recent Advances in Rare Cancers: From Bench to Bedside and Back (Deadline: 20 December 2023)
- PI3K Pathway in Cancer (Deadline: 22 December 2023)
- Current Status and Clinical Developments in Lung Cancer: What to Expect from Emerging Drugs? (Deadline: 29 December 2023)
- Ibrutinib in Chronic Lymphocytic Leukemia (Deadline: 30 December 2023)
- The Application of Laparo-Endoscopic and Robotic Surgery in Cancer Treatments and Research (Deadline: 30 December 2023)
- Advances in Surgical Treatment of Early-Stage Non-small Cell Lung Cancer (Deadline: 30 December 2023)
- Adaptive Resistance to Targeted Cancer Therapies and Rational Development of Combination Therapies (Deadline: 30 December 2023)
- Estrogens and Estrogen Receptor Modulators in Cancer Research and Therapy (Volume II) (Deadline: 31 December 2023)
- Contemporary Treatment of Colorectal Cancer (Deadline: 31 December 2023)
- Genomics-Guided Radiotherapy in Cancer (Deadline: 31 December 2023)
- Neoadjuvant Immunotherapy in Genitourinary Tumors (Deadline: 31 December 2023)
- An Update on Surgical Treatment for Hepato-Pancreato-Biliary Cancers (Deadline: 31 December 2023)
- New Therapies and Immunological Findings in Nasopharyngeal Carcinoma (Deadline: 31 December 2023)
- Liquid Biopsy in Cancer 2.0 (Deadline: 31 December 2023)
- Advances in Cytoreductive Surgery and Intraperitoneal Chemotherapy (Deadline: 31 December 2023)
- The Influence of Advances in Head and Neck Imaging on Diagnosis and Treatment of Head and Neck Squamous Cell Carcinoma (Deadline: 31 December 2023)
- Adjuvant Therapy for Pancreatic Cancer (Deadline: 31 December 2023)
- Innovative Supportive Approaches for Brain Tumor Patients and Caregivers (Deadline: 31 December 2023)
- Remote-Controlled Therapeutics for Cancer Therapy and Imaging (Deadline: 31 December 2023)
- Towards a Tailored Treatment of Chronic Lymphocytic Leukemia (Deadline: 31 December 2023)
- New Therapeutic Strategies of Radioresistant Tumours by Radiosensitization (Deadline: 31 December 2023)
- Class 2 Tumor Suppressor Gene Pathways for Therapeutic Applications in Hard-to-Treat Cancers (Deadline: 31 December 2023)
- Abiraterone Therapy for Prostate Cancer (Deadline: 31 December 2023)
- Comprehensive Review on Upper Tract Urothelial Carcinoma: An Update in 2023 (Deadline: 31 December 2023)
- Recent Advancement for the Treatment of Hepatocellular Carcinoma (Deadline: 31 December 2023)
- Surgical Treatment of Bone Metastases (Deadline: 31 December 2023)
- Impact of Surgery on Brain Cancer and Other Central Nervous System Tumors (Deadline: 31 December 2023)
- New Insights into the Use of Cytotoxic Agents for Cancer Treatment (Deadline: 31 December 2023)
- Innovative Prognostic Factors and Follow-Up of Localized Thoracic Malignancies (Deadline: 31 December 2023)
- Novel Therapeutic Approaches in Neuroendocrine Tumors (Deadline: 31 December 2023)
- The Up-to-Date of Endoscopic Submucosal Dissection (ESD) in Early Cancers (Deadline: 31 December 2023)
- Targeted Therapy for Androgen Receptor Signaling Inhibitors (ARSI)-Resistant Prostate Cancer (Deadline: 31 December 2023)
- Advances in Surgical Management of Colorectal Liver Metastases: Toward a Better Patient Selection, Lower Surgical Stress, and Multidisciplinary Approach (Deadline: 31 December 2023)
- Cancer Therapy: Where We Are and Where We Need to Go (Deadline: 31 December 2023)
- The Use of Combination Therapies to Treat Castration-Resistant Prostate Cancer 2.0 (Deadline: 31 December 2023)
- Cancer Stem Cells and Targeted Therapy (Deadline: 31 December 2023)
- Research Progress of Prostate Cancer Stem Cell Inhibitors (Deadline: 31 December 2023)
- Surgical Treatments and Modern Techniques in Colorectal Cancer (Deadline: 31 December 2023)
- Particle Therapy: State-of-the-Art and Future Prospects (Deadline: 31 December 2023)
- Advanced Ovarian Cancer (Deadline: 31 December 2023)
- Imaging of Cancer and Radiation Therapy: Recent Advances and Challenges (Deadline: 31 December 2023)
- Advances in the Management of Oligometastatic Disease in Non-colorectal Non-neuroendocrine Tumors (Deadline: 31 December 2023)
- Biliary Tract Tumors: Update in Diagnosis and Treatment (Deadline: 31 December 2023)
- Image-Guided Radiotherapy for Cancers (Deadline: 31 December 2023)
- Targeted Therapy for Bladder Cancer (Deadline: 31 December 2023)
- Advanced in Targeted Therapies in Cancer (Deadline: 31 December 2023)
- Non-coding RNA in Gastrointestinal Tumours: New Opportunities for Diagnosis and Treatment (Deadline: 31 December 2023)
- The Outcome of Radiation Therapy in Breast Cancer (Deadline: 10 January 2024)
- Hepatocellular Carcinoma: Current Treatment Strategies for Advanced Disease and Recurrence (Deadline: 10 January 2024)
- Radiation Dose in Cancer Radiotherapy (Deadline: 15 January 2024)
- Stem Cell Transplant and Cellular Therapies on Multiple Myeloma (Deadline: 15 January 2024)
- Thyroid Cancer: Diagnosis, Prognosis and Treatment (Deadline: 15 January 2024)
- Neoadjuvant Therapy of Pancreatic Cancer (Deadline: 15 January 2024)
- Salivary Glands Tumors, Head and Neck Tumors and Thymoma: Current Understanding and Future Personalized Therapeutic Approach (Deadline: 15 January 2024)
- New Trends in Esophageal Cancer Management (Volume II) (Deadline: 20 January 2024)
- Radiotherapy for Head and Neck Squamous Cell Carcinoma (Deadline: 20 January 2024)
- Glioblastoma: Recent Advances and Challenges (Deadline: 20 January 2024)
- Treatment Strategies and Emerging Biomarkers in High Risk Early-Stage Melanoma (Deadline: 20 January 2024)
- Advances in Thoracic Oncology (Deadline: 24 January 2024)
- The Emerging Role of Ion Channels in Cancer Treatment (Deadline: 30 January 2024)
- Preoperative Chemoradiotherapy for Gastrointestinal Cancer (Deadline: 30 January 2024)
- Novel Therapies for Gastrointestinal Cancers (Deadline: 31 January 2024)
- Stereotactic Radiotherapy in Tumor Ablation (Deadline: 31 January 2024)
- Application of Human Three-Dimensional Multicellular Models for Personalized Cancer Therapy (Deadline: 31 January 2024)
- The Latest Findings of the Comprehensive Management of Intrahepatic Hepatocellular Carcinoma through the Combined Use of Lenvatinib and Locoregional Therapies (Deadline: 31 January 2024)
- Breast Cancer and Hormone-Related Therapy (Deadline: 31 January 2024)
- Venetoclax in Acute Myeloid Leukemia (Deadline: 31 January 2024)
- Advance Research in Thrombosis and Hematologic Malignancies (Deadline: 31 January 2024)
- Advances in Diagnosis and Treatment for Bone and Soft Tissue Sarcoma (Deadline: 31 January 2024)
- Therapeutic Nanoparticles for Drug Delivery in Cancer (Deadline: 31 January 2024)
- Advances in Radiation Immuno-Oncology: Progress at the Interface of Radiation Oncology and Immunotherapy—A Themed Issue in Honor of Prof. Dr. Gabriele Multhoff (Deadline: 31 January 2024)
- Recent Research on Immunotherapy in Ovarian Cancer (Deadline: 31 January 2024)
- Advances in Invasive Breast Cancer: Treatment and Prognosis (Deadline: 31 January 2024)
- Study and Treatment of Oral Squamous Cell Carcinoma (Volume II) (Deadline: 31 January 2024)
- Her2-Positive Cancers and Antibody-Based Treatment: State of the Art and Future Developments (Volume II) (Deadline: 5 February 2024)
- Novel Combination Therapies for Acute Leukemia (Deadline: 10 February 2024)
- Skin Cancers as a Paradigm Shift: From Pathobiology to Treatment (Deadline: 15 February 2024)
- Neoadjuvant and Adjuvant Therapy for Gynecologic Malignancies (Deadline: 15 February 2024)
- Clinical Research for Hematopoietic Stem Cell Transplant and Cellular Therapy (Deadline: 20 February 2024)
- New Findings in Targeting Cancer Proteins (Deadline: 20 February 2024)
- New Approaches to Biology and Treatment of Acute Leukemia (Deadline: 20 February 2024)
- MRI-Guided Real-Time Adaptive Radiotherapy (Deadline: 20 February 2024)
- Research of Neurosurgery for Brain Tumors (Deadline: 23 February 2024)
- Molecular Markers and Targeted Therapy for Hepatobiliary Tumors (Deadline: 28 February 2024)
- Advances in Thoracic Oncology Research (Deadline: 28 February 2024)
- Management of Pancreatic Cancer (Deadline: 29 February 2024)
- Evolution of B-Cell Malignancy Therapy and Treatment Resistance: Where Are We Headed? (Deadline: 29 February 2024)
- The Role of Stereotactic Ablative Radiotherapy in the Management of Localized and Metastatic Genitourinary Tumours (Deadline: 29 February 2024)
- New Insights to Cancer Therapy Resistance (Deadline: 29 February 2024)
- Hepatobiliary Cancers: Infection, Inflammation and Therapy (Deadline: 29 February 2024)
- Oesogastric Cancer: Treatment and Management (Deadline: 29 February 2024)
- Advances in Modern Radiation Oncology (Deadline: 29 February 2024)
- The Gene Therapy of Glioblastoma: New Targeted Approaches (Deadline: 29 February 2024)
- Recent Advances in the Understanding of Myelodysplastic Syndrome and Acute Myeloid Leukemia (Deadline: 29 February 2024)
- Advances in the Diagnosis and the Management of Intracranial Tumors (Deadline: 29 February 2024)
- From Genomics and Immunogenomics to Treatments of Head and Neck Cancer (Deadline: 29 February 2024)
- Study on Tumor Suppressor Genes of Prostate Cancer (Deadline: 29 February 2024)
- Current Status of Neuroendocrine Tumors with a Special Focus on Diagnosis and Novel Treatments-Volume II (Deadline: 29 February 2024)
- Treatment Outcomes in Older Adults with Cancer (Deadline: 29 February 2024)
- Combination Therapy for Hepatocellular Carcinoma (Deadline: 29 February 2024)
- Advances in the Management of Pelvic Tumors (Deadline: 29 February 2024)
- Acute Myeloid Leukemia: From Diagnosis to Treatment (Deadline: 1 March 2024)
- Advances in Head and Neck Squamous Cell Carcinoma (Deadline: 1 March 2024)
- Recent Updates on Surgical Treatment of Pancreaticobiliary Cancers (Deadline: 10 March 2024)
- State-of-the-Art Mechanisms of Drug Resistance to Targeted Therapy in Cancers (Deadline: 10 March 2024)
- 2nd Edition: Imaging and Therapy in Lung Cancer and Mesothelioma (Deadline: 15 March 2024)
- Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Cancer Therapy (Deadline: 15 March 2024)
- Advances in Surgery of Head and Neck Squamous Cell Carcinoma (Deadline: 15 March 2024)
- Pediatric Cancers: Insights and Novel Therapeutic Approaches (Deadline: 15 March 2024)
- Innovations in the Treatment of Urothelial Cancer (Deadline: 15 March 2024)
- Acute Promyelocytic Leukemia (APML) (Deadline: 15 March 2024)
- Targeted Radiation Therapy and Molecular Imaging in Neuroendocrine Cancer (Deadline: 19 March 2024)
- New Strategies in Diagnosis and Treatments for Brain Tumors (Volume II) (Deadline: 20 March 2024)
- Novel Non-genomic Mechanism-Based Therapy against Melanoma (Deadline: 20 March 2024)
- Research on Early-Stage Breast Cancer: Management and Treatment (Deadline: 25 March 2024)
- Curative Therapies for Non-small Cell Lung Cancer (Deadline: 29 March 2024)
- Current Challenges and Opportunities in Treating Glioma (Deadline: 29 March 2024)
- Technological Development for Advancing the Frontiers in Cancer Research and Precision Oncology (Deadline: 29 March 2024)
- Recent Advances in Pancreatic Surgery for Pancreatic Ductal Adenocarcinoma (Deadline: 30 March 2024)
- Advances in Chemoradiotherapy for Gastrointestinal Cancers: From Bench to Bedside (Deadline: 30 March 2024)
- Post-neoadjuvant Strategies in Breast Cancer (Deadline: 31 March 2024)
- Advances in Pharmacotherapy of Hepatocellular Carcinoma (Deadline: 31 March 2024)
- Pulmonary Oncology Research (Deadline: 31 March 2024)
- New Insights into Surgical Treatment of Hepatocellular Carcinoma (Deadline: 31 March 2024)
- Advances in Radiotherapy for Head and Neck Cancer (Deadline: 31 March 2024)
- Novel Targeted Therapies for T-cell Malignancies (Deadline: 31 March 2024)
- Triple Negative Breast Cancer Therapy Resistance and Metastasis (Deadline: 31 March 2024)
- Hodgkin Lymphoma: Present Status and Future Strategies (Deadline: 31 March 2024)
- Contemporary Management for Gallbladder Cancer: From Diagnosis to Treatment (Deadline: 31 March 2024)
- Communication and Accessibility in the Tumor Microenvironment as a Therapeutic Target (Deadline: 31 March 2024)
- Clinical and Surgical Outcomes in the Management of Extremity Soft Tissue Sarcomas (Deadline: 31 March 2024)
- Advancements in Surgical Approaches for Gynecological Cancers (Deadline: 31 March 2024)
- Partial Breast Radiotherapy: Evidence and Challenges (Deadline: 31 March 2024)
- Advances in Human-Papillomavirus-Related Squamous Cell Carcinoma: From Pathogenesis to Treatment (Deadline: 31 March 2024)
- Radionuclides in Diagnostics and Therapy of Malignant Tumors: New Development (Volume II) (Deadline: 31 March 2024)
- Targeting Mechanisms of Protein Degradation for Cancer Therapy—Volume II (Deadline: 31 March 2024)
- Tyrosine Kinase Inhibitors (TKIs) in Cancer Targeted Therapy (Volume II) (Deadline: 31 March 2024)
- New Insights into Urologic Oncology (Deadline: 31 March 2024)
- Castration-Resistant Prostate Cancer: Progress and Promise (Deadline: 31 March 2024)
- Update on Pathogenesis and Treatment of Kaposi’s Sarcoma (Deadline: 5 April 2024)
- 2nd Edition: Combination and Innovative Therapies for Pancreatic Cancer (Deadline: 10 April 2024)
- Surgical Treatment of Spinal Tumors (Deadline: 15 April 2024)
- Advances in Stereotactic Radiotherapy of Brain Metastases (Deadline: 15 April 2024)
- State-of-the-Art and Perspectives in the Treatment of Hormone-Receptor-Positive Breast Cancer (Deadline: 15 April 2024)
- Novel Therapeutic Targets and Management in Pediatric Cancer (Deadline: 19 April 2024)
- Hematologic Malignancies: Challenges from Diagnosis to Treatment (Deadline: 30 April 2024)
- CAR T Therapy of Solid Cancers: Problems and Progress (Deadline: 30 April 2024)
- Gene and Cell Therapy for Cancers (Deadline: 30 April 2024)
- Neoadjuvant Therapy for Locally-Advanced Rectal Cancer (Deadline: 30 April 2024)
- Therapeutic Approaches for Myeloproliferative Neoplasms (Deadline: 30 April 2024)
- Hepatocellular Carcinoma: Advances and Challenges in Research and Treatment (Deadline: 30 April 2024)
- Endometrial Cancer: Old Questions and New Perspectives (Volume II) (Deadline: 30 April 2024)
- Radiation Therapy for Pancreatic Cancer (Deadline: 30 April 2024)
- Breast-Conserving Therapy for Breast Cancer (Deadline: 30 April 2024)
- Immunotherapy for Hepatocellular Carcinoma: Novel Experimental Approaches and Biomarkers (Deadline: 30 April 2024)
- Treg Cell Immunotherapy in Cancer (Deadline: 30 April 2024)
- The Effect of Radiation Therapy on the Tumor Ecosystem (Deadline: 1 May 2024)
- Advances in Surgical Treatment of Urinary Tumors (Deadline: 1 May 2024)
- Innovative Treatment Strategies for Lung Cancer and Radiotherapy (Deadline: 15 May 2024)
- Feature Review for Cancer Therapy (Deadline: 15 May 2024)
- Novel Therapeutic Strategies in Salivary Gland Tumor (Deadline: 18 May 2024)
- Chemotherapy for Primary Liver Cancer: Recent Updates and Future Perspectives (Deadline: 20 May 2024)
- The Genetic Analysis and Clinical Therapy in Lung Cancer (Deadline: 20 May 2024)
- Advances in Interventional Oncologic Therapies (Deadline: 25 May 2024)
- Mesothelioma—from Diagnosis to Treatment (Deadline: 30 May 2024)
- The Surgical Management of Colorectal Cancer (Deadline: 31 May 2024)
- New Insights into Kidney Disease Development and Therapy Strategies (Deadline: 31 May 2024)
- Novel Approaches to Gynecologic Cancers Biology and Treatment (Deadline: 31 May 2024)
- Interventional Radiology in Cancer Treatment (Deadline: 31 May 2024)
- Surgery or Radiotherapy for Primary and Oligometastatic Lung Cancer (Deadline: 31 May 2024)
- New Approaches to the Surgical Treatment for Radical Cystectomy in Bladder Cancer (Deadline: 31 May 2024)
- Combination Therapy in Geriatric Population with Cancer (Deadline: 31 May 2024)
- Challenges and Opportunities for Novel Therapeutic Strategies in Pediatric Oncology (Deadline: 1 June 2024)
- Multimodality Management of Sarcomas (Deadline: 10 June 2024)
- Beginning of a New Era: Current Progress in Colorectal Cancer Detection, Treatment, and Prognosis (Deadline: 20 June 2024)
- Novel Experimental Therapeutic Targets and Strategies for Brain Tumors (Deadline: 20 June 2024)
- Novel Targeted Therapy, Immunotherapy, and Immune Biomarkers for Gastroesophageal and Liver Cancer (Deadline: 30 June 2024)
- Advances in Brachytherapy in the Treatment of Tumors (Deadline: 30 June 2024)
- Neurosurgical Management of Gliomas (Deadline: 30 June 2024)
- Gastric Cancer: Evolving Landscape and Emerging Therapies (Deadline: 30 June 2024)
- Current Progress and Research Trends in Ocular Oncology (Deadline: 30 June 2024)
- Advances in the Prevention and Treatment of Liver Cancer (Deadline: 30 June 2024)
- Neoadjuvant Chemotherapy for Breast Cancer (Deadline: 30 June 2024)
- Pancreatic Cancer Treatment: Immunotherapy, Chemotherapy, Chemoradiation, and Targeted Therapy (Deadline: 30 June 2024)
- Diagnosis and Treatment for Hepatocellular Tumors (Volume II) (Deadline: 30 June 2024)
- Setting the Standards for Malignancies of the Nose Vestibule (Deadline: 30 June 2024)
- New Challenges for Gastric Cancer—Gut Microbiota, Post-Eradication, Chemotherapy, etc. (Deadline: 30 June 2024)
- Current Progress in Proton Radiotherapy of Cancer (Deadline: 30 June 2024)
- Surgery for Osteosarcoma (Deadline: 1 July 2024)
- Correlating Patient-Reported Quality of Life before, during, and after Therapy with Objective Measures and Outcomes (Deadline: 5 July 2024)
- Resistance to Therapies in Hepatocellular Carcinoma (Deadline: 15 July 2024)
- Recent Advances in Drug Delivery for Cancer Therapy (Deadline: 15 July 2024)
- Advancements in Lung Cancer Surgical Treatment and Prognosis (Deadline: 15 July 2024)
- Research on Early Diagnosis and Treatment of Gastric Cancer (Deadline: 25 July 2024)
- Research on Current Progress in Penile Cancer (Deadline: 25 July 2024)
- The Role of Cytoreductive Surgery in Cancers (Deadline: 31 July 2024)
- Cancer Chemotherapy: Combination with Inhibitors (Volume II) (Deadline: 31 July 2024)
- Drug Delivery for Cancer Therapy (Deadline: 31 July 2024)
- Protein Synthesis in Cancer Cells: Mechanisms and Novel Targeted Therapies (Volume II) (Deadline: 31 July 2024)
- Relevant Prognostic Factors in Gastric Cancer (Deadline: 5 August 2024)
- Minimally Invasive Surgery in the Treatment of Urological Cancers (Deadline: 10 August 2024)
- Advances and Challenges in RAS-Directed Cancer Therapy (Deadline: 10 August 2024)
- The Uprising Role of Histone Deacetylase Inhibitors in Cancer Therapy (Deadline: 20 August 2024)
- Advances in the Prognosis of Gastrointestinal Cancers (Deadline: 31 August 2024)
- Perioperative and Surgical Management of Gastrointestinal Cancers (Deadline: 31 August 2024)
- Advance of Particle Therapy in Prostate Cancer (Deadline: 10 September 2024)
- Advances in Cancer Therapeutics (Deadline: 20 September 2024)
- Neoadjuvant Therapy of Breast Cancer (Deadline: 20 September 2024)
- Radiochemotherapy, Radioimmunotherapy and Targeted Therapy in Locally Advanced and Metastatic Head and Neck Cancer (Deadline: 20 September 2024)
- Circadian Rhythms, Cancers and Chronotherapy (Deadline: 30 September 2024)
- Liver Cancer: Improving Standard Diagnosis and Therapy (Volume II) (Deadline: 25 October 2024)
- Advancing Hepatocellular Imaging: Innovations in Diagnosis, Prognosis, and Treatment Response Assessment (Deadline: 1 December 2024)
- Nuclear Receptors in the Etiology and Treatment of Cancer (Deadline: 1 December 2024)
- Surgical Treatment of Endocrine Cancer (Deadline: 1 December 2024)
- CWC2024: Practical Approaches to Cancer Diagnosis, Staging, Prognosis and Therapy (Deadline: 12 December 2024)
- Combination Therapies for Brain Tumors (Deadline: 31 December 2024)
- Rapid Diagnostics for Antimicrobial Resistance in Cancer Patients (Deadline: 31 December 2024)
- Tumor Suppressor and Targeted Therapy in Hepatocellular Carcinoma: From Diagnosis to Treatment (Deadline: 31 December 2024)
- Advances in Therapeutic Approaches Targeting Pediatric and Adult Glioma (Deadline: 31 December 2024)
- Breast Cancer: Tailored Rehabilitation Strategies to Address the Challenge of Survivorship Issues (Deadline: 3 July 2025)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Advances in Geriatric Oncology: Exploring Practical Ways to Optimize Treatment in Older Patients with Cancer
- Advances in Multiple Myeloma Research and Treatment
- Advances in the Management of Hepatocellular Carcinoma
- Breast Cancer: From Pathophysiology to Prevention and Treatment (Closed)
- Cancer Nanomedicine
- Combination Therapies in Cancers
- Emerging Therapeutics in Advanced Melanoma
- Hyperthermia in Cancer Therapy
- Innovative Concepts in the Diagnosis and Treatment of Gynecologic Malignancies
- Ion Channels in Cancer Therapies
- Neuroendocrine Tumors: Treatment and Management
- New Treatment for Colorectal Cancer
- Novel Therapies for Hepatocellular Carcinoma
- Oncology: State-of-the-Art Research in the USA
- Plasma Oncology
- Prostate Cancer Radiotherapy: Recent Advances and Challenges
- Prostate Cancer: Pathophysiology, Pathology and Therapy
- Targeted Cancer Therapy
- Targeted Therapies and Immunotherapies in Metastatic Melanoma
- Treatment of Glioma
- Treatment of Hepatocellular Carcinoma and Cholangiocarcinoma
- Urological Cancer